Sign inJoin waitlistJoin the waitlist

JJ

Jewel Johl

MD · John Muir Health

Credentials: · · ·

History

John Muir Medical Center Walnut Creek
2024–Present

University of California Davis Health
2001–2003
Internal Medicine
1998–2001
Loyola University Chicago Stritch School of Medicine
1994–1998

Research

Frequent expression of the tumor necrosis factor receptor-associated factor 1 in latent membrane protein 1-positive posttransplant lymphoproliferative disease and HIV-associated…
Human Pathology · 2001 · 12 citations
Population-based phase I trial of irinotecan and epirubicin
American Journal of Clinical Oncology · 2008 · 2 citations
A population-based clinical trial of irinotecan and Carboplatin
Journal of Oncology · 2009 · Last of 3 authors

DL
Derick Lau
2 papers
MH
Minh Huynh
2 papers
AF
Alexandra Filipovich
1 paper
AD
Angela Davies
1 paper
David Gandara
1 paper
LS
Lode Swinnen
1 paper
MG
Margaret Gulley
1 paper
MR
Margaret Ragni
1 paper
MT
Michael Tanaka
1 paper
Primo Lara
1 paper
RA
Richard Ambinder
1 paper

Clinical trials

A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Site PI · Recruiting · Phase 2
Eli Lilly and Company
2025–2027
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2032
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2023–2031